Tonix Pharmaceuticals is a pharmaceutical company that develops and makes drugs. Its lobbying filings show it is asking Congress for federal funding tied to developing new treatments for post-traumatic stress disorder (PTSD) and COVID-19, including through BARDA appropriations (BARDA is the Biomedical Advanced Research and Development Authority). It has reported about $100,000 in lobbying across multiple filings and used Broydrick & Associates as its lobby firm.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
WILLIAM B BROYDRICK
The latest disclosures for this client.
BROYDRICK & ASSOCIATES
Q4BROYDRICK & ASSOCIATES
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
BROYDRICK & ASSOCIATES
BROYDRICK & ASSOCIATES
Q3BROYDRICK & ASSOCIATES
Q2BROYDRICK & ASSOCIATES
Q1